CoChat

Characterizing the Clinical and Genetic Spectrum of Polycystic Ovary Syndrome in Electronic Health Records

Open access
Actkins, Ky’Era V, Singh, Kritika, Hucks, Donald, Velez Edwards, Digna R, Aldrich, Melinda, Cha, Jeeyeon, Wellons, Melissa, Davis, Lea K · 2021 · The Journal of Clinical Endocrinology & Metabolism

Published version of a preprint

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Context: Polycystic ovary syndrome (PCOS) is one of the leading causes of infertility, yet current diagnostic criteria are ineffective at identifying patients whose symptoms reside outside strict diagnostic criteria. As a result, PCOS is underdiagnosed and its etiology is poorly understood. Objective: We aim to characterize the phenotypic spectrum of PCOS clinical features within and across racial and ethnic groups. Methods: We developed a strictly defined PCOS algorithm (PCOSkeyword-strict) using the International Classification of Diseases, ninth and tenth revisions and keywords mined from clinical notes in electronic health records (EHRs) data. We then systematically relaxed the inclusion criteria to evaluate the change in epidemiological and genetic associations resulting in 3 subsequent algorithms (PCOScoded-broad, PCOScoded-strict, and PCOSkeyword-broad). We evaluated the performance of each phenotyping approach and characterized prominent clinical features observed in racially and ethnically diverse PCOS patients. Results: The best performance came from the PCOScoded-strict algorithm, with a positive predictive value of 98%. Individuals classified as cases by this algorithm had significantly higher body mass index (BMI), insulin levels, free testosterone values, and genetic risk scores for PCOS, compared to controls. Median BMI was higher in African American females with PCOS compared to White and Hispanic females with PCOS. Conclusions: PCOS symptoms are observed across a severity spectrum that parallels the continuous genetic liability to PCOS in the general population. Racial and ethnic group differences exist in PCOS symptomology and metabolic health across different phenotyping strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgaa675

Cites

Statistics

Figures

Figure 1. Polycystic ovary syndrome (PCOS) algorithm pipeline. This schematic illustrates the algorithm development steps for the controls and the 4 PCOS algorithms. The Venn diagram illustrates how the algorithm data sets are nested within one another. Each color corresponds with one of the algorithm data sets. ICD, International Classification of Diseases, 9th and 10th revision.
Figure 1. Polycystic ovary syndrome (PCOS) algorithm pipeline. This schematic illustrates the algorithm development steps for the controls and the 4 PCOS algorithms. The Venn diagram illustrates how the algorithm data sets are nested within one another. Each color corresponds with one of the algorithm data sets. ICD, International Classification of Diseases, 9th and 10th revision.CC BY · PubMed Central
Figure 2. Laboratory measurements for polycystic ovary syndrome (PCOS) algorithm cases and controls. Box plots of A, body mass index (BMI) measurements; B, insulin levels; C, estradiol levels; and D, free testosterone levels for PCOS algorithm cases and controls. Colored boxes represent races. Boxes represent the individuals with lab measurements in the 25th and 75th percentile. Lines above and below the boxes represent the 95th and 5th quartiles. Lines within each box mark the median. Wilcoxon rank sum tests were performed between algorithm cases and controls and brackets display the P values of the statistical test.
Figure 2. Laboratory measurements for polycystic ovary syndrome (PCOS) algorithm cases and controls. Box plots of A, body mass index (BMI) measurements; B, insulin levels; C, estradiol levels; and D, free testosterone levels for PCOS algorithm cases and controls. Colored boxes represent races. Boxes represent the individuals with lab measurements in the 25th and 75th percentile. Lines above and below the boxes represent the 95th and 5th quartiles. Lines within each box mark the median. Wilcoxon rank sum tests were performed between algorithm cases and controls and brackets display the P values of the statistical test.CC BY · PubMed Central
Figure 3. Comparison of laboratory measurements between White (W), African American (AA), and Hispanic (HIS) polycystic ovary syndrome (PCOS) algorithm cases and controls. Box plots of A, body mass index (BMI) measurements; B, insulin levels; C, estradiol levels; and D, free testosterone levels for W, AA, and HIS PCOS cases and controls. Colors correspond with each race. Boxes represent the 25th and 75th quartiles. Lines above and below the boxes represent the 95th and fifth quartiles. Lines within each box mark the median. Wilcoxon rank sum tests were performed between races within the PCOS cases and control data sets. Brackets display the P values of the statistical test.
Figure 3. Comparison of laboratory measurements between White (W), African American (AA), and Hispanic (HIS) polycystic ovary syndrome (PCOS) algorithm cases and controls. Box plots of A, body mass index (BMI) measurements; B, insulin levels; C, estradiol levels; and D, free testosterone levels for W, AA, and HIS PCOS cases and controls. Colors correspond with each race. Boxes represent the 25th and 75th quartiles. Lines above and below the boxes represent the 95th and fifth quartiles. Lines within each box mark the median. Wilcoxon rank sum tests were performed between races within the PCOS cases and control data sets. Brackets display the P values of the statistical test.CC BY · PubMed Central
Figure 4. Race-stratified laboratory measurements for polycystic ovary syndrome (PCOS) algorithm cases and controls. Box plots of A, body mass index (BMI) measurements; B, insulin levels; C, estradiol levels; and D, free testosterone levels of race stratified PCOS algorithm data sets. Each color corresponds with a race. Boxes represent the 25th and 75th quartiles. Lines above and below the boxes represent the 95th and fifth quartiles. Lines within each box mark the median. Wilcoxon rank sum tests were performed between algorithm cases and controls within each race. Brackets display the P values of the statistical test. CB, coded broad; CN, controls; CS, coded strict; RB, keyword broad; RS, keyword strict.
Figure 4. Race-stratified laboratory measurements for polycystic ovary syndrome (PCOS) algorithm cases and controls. Box plots of A, body mass index (BMI) measurements; B, insulin levels; C, estradiol levels; and D, free testosterone levels of race stratified PCOS algorithm data sets. Each color corresponds with a race. Boxes represent the 25th and 75th quartiles. Lines above and below the boxes represent the 95th and fifth quartiles. Lines within each box mark the median. Wilcoxon rank sum tests were performed between algorithm cases and controls within each race. Brackets display the P values of the statistical test. CB, coded broad; CN, controls; CS, coded strict; RB, keyword broad; RS, keyword strict.CC BY · PubMed Central
Figure 5. Genetic validation of polycystic ovary syndrome (PCOS) algorithms. Logistic regressions were performed between PCOS case status and PCOS polygenic risk scores (PCOSPRS). The regression models were adjusted for median age and the first 10 principal components. P values are displayed for each regression model. Colors correspond to the genotyped sample used in the analysis. OR, odds ratio.
Figure 5. Genetic validation of polycystic ovary syndrome (PCOS) algorithms. Logistic regressions were performed between PCOS case status and PCOS polygenic risk scores (PCOSPRS). The regression models were adjusted for median age and the first 10 principal components. P values are displayed for each regression model. Colors correspond to the genotyped sample used in the analysis. OR, odds ratio.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 46 · Cited by 27

Research works printed but not linked: 1

  1. Actkins, 2020, Data from: Characterizing the clinical and genetic spectrum of polycystic ovary syndrome in electronic health records, figshare

Metadata

Authors
Actkins, K. V., Singh, K., Hucks, D., Velez Edwards, D. R., Aldrich, M., Cha, J., Wellons, M., & Davis, L. K.
Affiliations
  • Meharry Medical College (US)
  • Vanderbilt University Medical Center (US)
  • Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, Tennessee
Corresponding author
Davis, Lea K
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2020-09-22
Volume
106
Issue
1
Pages
153-167
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W3087830223
Cited by
27
References
46
Citations by year
2026: 2 · 2025: 4 · 2024: 2 · 2023: 13 · 2022: 4 · 2021: 2
FWCI
4.17
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (5T32GM007628-42, 5T32DK007061, U54MD010722, S10RR025141, UL1TR002243, UL1TR000445, UL1RR024975, U01HG004798, R01NS032830, RC2GM092618, P50GM115305, U01HG006378, U19HL065962, R01HD074711)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Keywords
polycystic ovary syndrome, electronic health records, racial and ethnic differences, body mass index, insulin, free testosterone, polygenic risk score, infertility, underdiagnosis, phenotypic spectrum
MeSH terms
Adolescent, Adult, Algorithms, Data Interpretation, Statistical, Ethnicity, Female, Humans, Phenotype, Polycystic Ovary Syndrome, Predictive Value of Tests, Risk Factors, Tennessee, Case-Control Studies, Genetic Predisposition to Disease, Multifactorial Inheritance, Racial Groups, Young Adult, Data Mining, Electronic Health Records

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterizing the Clinical and Genetic Spectrum of Polycystic Ovary Syndrome in Electronic Health Records. https://app.cochat.ai/papers/10.1210/clinem/dgaa675
The paper
Actkins, K. V., Singh, K., Hucks, D., Velez Edwards, D. R., Aldrich, M., Cha, J., Wellons, M., & Davis, L. K. (2021). Characterizing the Clinical and Genetic Spectrum of Polycystic Ovary Syndrome in Electronic Health Records. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaa675

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.